Live Breaking News & Updates on Double Mutant Virus

Stay updated with breaking news from Double mutant virus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID second wave: Mutant variants driving rise in high-burden states


COVID second wave: Mutant variants driving rise in high-burden states
On the strains, such as the double and triple mutant detected in India, they said all are the same variant of the virus, and the available vaccines are effective on them.
Share Via Email
  |  A+A A-
A healthcare worker prepares to collect a swab sample from a passenger at the Kempegowda Bus Station in Bengaluru on Sunday. (Photo | Shriram BN/EPS)
By Express News Service
NEW DELHI:  Experts engaged in genome analysis say that one of the reasons behind the surge in the Covid-19 cases could be increasing mutant variants in many cities, especially in high-burden states. ....

National Institute Of Biomedical Genomics , News Service , Express News , Biomedical Genomics , Soumitra Das , Ew Mutatn Strains , Uk Variant , Double Mutant Virus , Second Wave , தேசிய நிறுவனம் ஆஃப் உயிர் மருத்துவ மரபியல் , செய்தி சேவை , எக்ஸ்பிரஸ் செய்தி , உயிர் மருத்துவ மரபியல் , சூமித்ரா தாஸ் ,

Double and triple mutants of COVID-19 are same; vaccines effective on it: Scientist


Double and triple mutants of COVID-19 are same; vaccines effective on it: Scientist
There is apprehension among experts that the new variant could also increase infection rates and easily surpass immune defences.
By PTI|   Posted by Nikita Venkatesh  |   Updated: 23rd April 2021 6:34 pm IST
New Delhi: The double and triple mutant strains detected in India are one and the same variant of the coronavirus, and the available vaccines are effective on it, National Institute of Biomedical Genomics Director Soumitra Das said on Friday.
Speaking at a webinar on ‘Genome Sequencing of SARS-CoV-19’, Das said double mutant and triple mutant terms are “colloquial” and both refer to the same variant B.1.617 variant of the coronavirus. ....

New Delhi , Shaheed Jameel , Soumitra Das , National Institute Of Biomedical Genomics , National Institute Of Biomedical Genomics In Kalyani , Department Of Biotechnology , National Institute , Biomedical Genomics Director Soumitra Das , Genome Sequencing , Biomedical Genomics , Molecular Biology , Corona Virus , Covid 19 , Covid 19 Vaccine , Ovid 19 Variants , Double Mutant Virus , Molecular Biology , Ars Cov 2 , Riple Mutant Virus , புதியது டெல்ஹி , ஷாஹீத் ஜமீல் , சூமித்ரா தாஸ் , தேசிய நிறுவனம் ஆஃப் உயிர் மருத்துவ மரபியல் , தேசிய நிறுவனம் ஆஃப் உயிர் மருத்துவ மரபியல் இல் கல்யாணி , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் , தேசிய நிறுவனம் ,

Covaxin neutralises double mutant strain, effective against multiple variants of SARS-CoV-2: ICMR


Covaxin neutralises double mutant strain, effective against multiple variants of SARS-CoV-2: ICMR
Bharat Biotech s Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe.
Share
Updated: Apr 21, 2021, 04:01 PM IST
Indigenously-developed Covid-19 vaccine Covaxin, made by Bharat Biotech, neutralises multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.
ICMR study shows #COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the ICMR tweeted.
This development comes amid the second wave of the COVID-19 pandemic being witnessed across the country. ....

United States , Narendra Modi , Krishna Ella , Indian Council Of Medical Research , Serum Institute Of India , Bharat Biotech , Indian Council , Medical Research , Emergency Use Authorizations , Prime Minister Narendra Modi , Serum Institute , Covaxin Covid 19 , Covaxin Vaccine , Bharat Biotech Covaxin , Double Mutant Virus , Double Mutant Variant , Ovid 19 Variants India , Ovid 19 Variant Types , ஒன்றுபட்டது மாநிலங்களில் , நரேந்திர மோடி , கிருஷ்ணா எல்லா , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , சீரம் நிறுவனம் ஆஃப் இந்தியா , பாரத் பயோடெக் , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி ,